Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for improving efficiency of differentiation induced in vitro of cord blood megakaryocyte progenitor cells

A megakaryocyte progenitor cell and a technology for inducing differentiation, which is applied in the field of improving the in vitro differentiation efficiency of umbilical cord blood megakaryocyte progenitor cells, can solve the problems of adverse effects on the efficiency of hematopoietic stem cell expansion and differentiation, increased cost, pollution of operation steps, etc., and achieves low cost. , improve efficiency, reduce the effect of toxic effects

Active Publication Date: 2015-11-18
广州市天河诺亚生物工程有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Total nucleated cells contain a large number of cells of various types, and the complex composition adversely affects the efficiency of in vitro expansion and differentiation of hematopoietic stem cells
Although purer hematopoietic stem cells can be obtained by magnetic bead sorting to optimize the results of in vitro expansion and differentiation, the substantial increase in cost greatly restricts the need for large-scale expansion, and more operating steps also bring greater risk of contamination

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving efficiency of differentiation induced in vitro of cord blood megakaryocyte progenitor cells
  • Method for improving efficiency of differentiation induced in vitro of cord blood megakaryocyte progenitor cells
  • Method for improving efficiency of differentiation induced in vitro of cord blood megakaryocyte progenitor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Umbilical cord blood was collected from healthy pregnant women and infants. The tests for hepatitis B, hepatitis C, syphilis, AIDS, cytomegalovirus, mycoplasma, chlamydia, G-DPD and thalassemia were all negative. The transportation temperature of the specimens from collection to the blood bank is kept at 4-8°C, and they are transported to the cord blood bank within 24 hours. Perform directed differentiation of megakaryotic progenitor cells as follows:

[0058] (1) Preparation of resveratrol solution and specific medium

[0059] Resveratrol (≥99%, GC), dissolved in the cell protection agent, is prepared into a concentration of 10mmol / L resveratrol storage solution; then the resveratrol storage solution is added to the stem cell culture medium to obtain Type I stem cell medium of resveratrol; the final concentration of resveratrol in the stem cell medium is 50 μmol / L; another stem cell medium (type II stem cell medium) without any resveratrol component is set as Control...

Embodiment 2

[0082] Directed expansion of umbilical cord blood hematopoietic stem cells to megakaryotic progenitor cells with reference to the method of Example 1:

[0083] (1) On the first day after inoculation:

[0084] The initial cell mass (microscopic cell count) of the Control group and the treatment group (50 μmol / L resveratrol cultured for 72 hours) were respectively: 4.26 × 10 6 pcs / mL, 4.28×10 6 individual / mL.

[0085] (2) On the 6th day after inoculation:

[0086] Microscopic cell counting results: the amount of cells in the Control group and the treatment group (50 μmol / L resveratrol cultured for 72 hours) were respectively: 3.34 × 10 6 pcs / mL, 2.61×10 6 a / mL;

[0087] Flow cytometry results: in CD41 + In terms of cell ratio, the values ​​of the Control group and the treatment group (50 μmol / L resveratrol cultured for 72 hours) were 6.35% and 10.38%, respectively.

[0088] (3) On the 12th day after inoculation:

[0089] Microscopic cell counting results: the cell amount...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of cells and particularly relates to a method for improving efficiency of differentiation induced in vitro of cord blood megakaryocyte progenitor cells. The method provided by the invention comprises the following steps: adding a type I stem cell culture medium containing 50mu mol / L resveratrol into cord blood total nucleated cells for culturing for 72 hours, and then changing a type II stem cell culture medium free of resveratrol for further culturing, thereby obviously improving the efficiency of differentiation of megakaryocyte progenitor cells. According to the invention, the type I stem cell culture medium containing 50mu mol / L resveratrol is firstly used for culturing, and then the type II stem cell culture medium free of resveratrol is used for for further culturing; according to the culture sequence of the two culture mediums, the efficiency of directional differentiation of cord blood hematopoietic stem cells to megakaryocyte progenitor cells can be obviously improved, and megakaryocyte progenitor cells with high purity can be prepared. The method is simple and reliable in process, good in repeatability, low in possibility of pollution as well as economical in preparation cost and safe in operation.

Description

technical field [0001] The invention belongs to the field of cell technology, and in particular relates to a method for improving the differentiation efficiency of umbilical cord blood megakaryocyte progenitor cells in vitro. Background technique [0002] After the world's first successful transplantation of umbilical cord blood hematopoietic stem cells in 1989, the clinical application of umbilical cord blood hematopoietic stem cells has become more and more extensive. After more than 20 years of development, umbilical cord blood has become hematopoietic stem cells together with bone marrow and peripheral blood. of the three sources. [0003] Compared with bone marrow, the recovery rate of platelets after cord blood transplantation is slightly slower. It is generally believed that the reason is that the number of megakaryotic progenitor cells in cord blood is insufficient and their differentiation and maturation are slow. Before hematopoietic stem cell transplantation, the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0789
Inventor 嵐山芮魏伟袁嘉恩
Owner 广州市天河诺亚生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com